MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling

MLA

Shao-Lai Zhou, et al. “MACROD2 Deficiency Promotes Hepatocellular Carcinoma Growth and Metastasis by Activating GSK-3β/β-Catenin Signaling.” NPJ Genomic Medicine, vol. 5, Oct. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e5360b8935f9e92eb7d1b4ce8c9ab569&authtype=sso&custid=ns315887.

APA

Shao-Lai Zhou, Hao-Yang Xin, Jia Li, Zhi-Qiang Hu, Gui-Qi Zhu, Zheng-Jun Zhou, & Chu-Bin Luo. (2019). MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling. NPJ Genomic Medicine, 5.

Chicago

Shao-Lai Zhou, Hao-Yang Xin, Jia Li, Zhi-Qiang Hu, Gui-Qi Zhu, Zheng-Jun Zhou, and Chu-Bin Luo. 2019. “MACROD2 Deficiency Promotes Hepatocellular Carcinoma Growth and Metastasis by Activating GSK-3β/β-Catenin Signaling.” NPJ Genomic Medicine 5 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e5360b8935f9e92eb7d1b4ce8c9ab569&authtype=sso&custid=ns315887.